Page last updated: 2024-08-25

5-hydroxymethylcytosine and Cancer of Cervix

5-hydroxymethylcytosine has been researched along with Cancer of Cervix in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Asanoma, K; Cui, L; Hori, E; Itakura, A; Kato, K; Kato, M; Kawakami, M; Kawamura, K; Kodama, K; Matsumura, Y; Onoyama, I; Takeda, S; Yagi, H; Yahata, H; Yoshida, S1
Bhat, S; Chakrabarty, S; Kabekkodu, SP; Kushtagi, P; Mallya, SP; Pandey, D; Rotti, H; Satyamoorthy, K; Varghese, VK1
Balch, C; Chao, TK; Chen, CW; Chen, LY; Hsu, YW; Huang, RL; Lai, HC; Liao, CC; Mao, SP; Su, PH; Wu, TI1
Ding, Y; Su, Y; Tian, Y; Wang, J; Wang, X1
Han, CS; Li, PL; Zhang, LY; Zhang, XC1

Other Studies

5 other study(ies) available for 5-hydroxymethylcytosine and Cancer of Cervix

ArticleYear
Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia.
    PloS one, 2020, Volume: 15, Issue:11

    Topics: 5-Methylcytosine; Animals; Cytidine Deaminase; DNA (Cytosine-5-)-Methyltransferase 1; Down-Regulation; Female; Humans; Mice, Inbred C57BL; Minor Histocompatibility Antigens; Mixed Function Oxygenases; Proto-Oncogene Proteins; Tumor Suppressor Protein p53; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2020
Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:3

    Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; DNA Methylation; Female; Genotype; High-Throughput Nucleotide Sequencing; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Papillomaviridae; Promoter Regions, Genetic; Transcription Factors; Uterine Cervical Neoplasms

2017
TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions.
    Cancer letters, 2019, 05-28, Volume: 450

    Topics: 5-Methylcytosine; Animals; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; HeLa Cells; Heterografts; Humans; Mice; Mixed Function Oxygenases; Neoplastic Stem Cells; Precancerous Conditions; Proto-Oncogene Proteins; Squamous Intraepithelial Lesions of the Cervix; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vimentin; Zinc Finger E-box-Binding Homeobox 1

2019
Characterization of DNA hydroxymethylation profile in cervical cancer.
    Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1

    Topics: 5-Methylcytosine; Adult; DNA Methylation; Female; Genomics; Humans; Transcription, Genetic; Uterine Cervical Neoplasms

2019
5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma.
    Japanese journal of clinical oncology, 2016, Volume: 46, Issue:5

    Topics: 5-Methylcytosine; Adult; Carcinoma, Squamous Cell; Cervix Uteri; Dioxygenases; Disease-Free Survival; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Mixed Function Oxygenases; Multivariate Analysis; Prognosis; Proto-Oncogene Proteins; Uterine Cervical Neoplasms

2016